Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

Weight-loss injections known as GLP-1 receptor agonists could nearly halve the risk of obesity-related cancers, according to ...

Restricting the eating window to 8 hours at any time of day for 3 months can result in significant weight loss for at least a ...

Eli Lilly's Zepbound surpassed Novo Nordisk's Wegovy in reducing waist circumference and overall weight loss in a recent ...

Mitolyn is a holistic weight loss supplement inspired by Harvard research, taking a refreshing and science-backed approach to ...

New research indicates that weight loss injections, or GLP-1 receptor agonists, may directly contribute to cancer risk ...

As the definitive trial comparing Wegovy to Mounjaro is released, experts stress the need for patients to be given the very ...

May 7, 2025 — People who eat more ultra processed foods like cold breakfast cereal, cookies and hot dogs are more likely to have early signs of Parkinson's disease when compared to those who eat ...

Losing even a moderate amount of weight is associated with reduced progression of diabetes, improved blood pressure and HDL ...

Following on from a remarkable study in mice, scientists have now confirmed that silencing a certain protein in muscle tissue ...